Classification
• Transudates (low protein, <30 g/L)
o Causes:
Heart failure (most common)
Hypoalbuminaemia (e.g., nephrotic syndrome, liver cirrhosis)
Constrictive pericarditis
• Exudates (high protein, >30 g/L)
o Causes:
Infection (parapneumonic, TB)
Malignancy (lung, breast, lymphoma)
Pulmonary embolism
Connective tissue disease (RA, SLE)
• Pleural fluid protein / serum protein >0.5
• Pleural fluid LDH / serum LDH >0.6
• Pleural fluid LDH > two-thirds upper limit of serum normal
Investigations
• CXR: blunting of costophrenic angle; lateral decubitus film shows layering
• Ultrasound: guides aspiration
• Diagnostic tap:
o pH <7.2 → empyema
o Low glucose → RA, empyema, TB, malignancy
o High amylase → pancreatitis, oesophageal rupture
Management
• Drainage if large, symptomatic, or infected (empyema)
• Treat underlying cause
Types
o Typically young, tall, thin men
o Subpleural blebs rupture
o Occurs with underlying lung disease (COPD, ILD, CF)
o E.g., central line insertion, positive-pressure ventilation
• Severe breathlessness, hypotension, tracheal deviation away, hyperresonant
• Emergency: immediate needle decompression
o Large bore cannula in 2nd ICS midclavicular line, then insert chest drain (5th ICS midaxillary line)
Management (British Thoracic Society)
• PSP
o <2 cm and no breathlessness → observe
o 2 cm or symptomatic → aspirate first, then drain if unsuccessful
• SSP
o 2 cm or symptomatic → chest drain
o <1 cm and asymptomatic → consider oxygen and observe
Features
• Malignant pleural tumour; strongly linked to asbestos exposure
• Long latency (~30–40 years)
Clinical
• Dyspnoea, pleuritic chest pain
• Recurrent unilateral pleural effusion
• Weight loss
Imaging
• CXR: unilateral effusion, pleural thickening, calcified pleural plaques (old asbestos exposure)
• CT: helps assess local invasion
Diagnosis
• Pleural fluid cytology (low yield)
• Thoracoscopic biopsy (definitive)
Prognosis
• Very poor; median survival ~12 months
Management
• Mainly palliative: pleurodesis, analgesia
• Chemotherapy (pemetrexed + cisplatin)
Extra Revision Pearls
• Transudate clues → systemic causes (e.g., HF, cirrhosis)
• Low pleural glucose → RA, empyema, TB, cancer
• High pleural amylase → think pancreatitis or oesophageal rupture
• Tension pneumothorax = clinical diagnosis → do not wait for CXR!
• Trachea deviates away from tension pneumothorax; towards collapse/effusion
• Asbestos exposure + recurrent effusion → mesothelioma until proven otherwise
• Bilateral pleural plaques → classic marker of asbestos exposure
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.